AMP 2020 Annual Meeting: Platform Presentations of Selected Hematopathology Abstracts 

Log in for pricing

(No reviews yet) Write a Review
SKU:
311AM20-014
This is a recording of a session from the AMP 2020 Annual Meeting & Expo. Purchase the entire AMP 2020 Annual Meeting & Expo recordings for a significant discount!

Platform presentations of selected Hematopathology abstracts.

H14 - Cloneretriever: An Automated Algorithm to Identify Clonal Immunoglobulin Gene Rearrangements by Next-generation Sequencing
Eitan Halper-Stromberg, MD PhD, JHU, Baltimore, MD, USA 

H21 - Validation of MYD88 L265P Ddpcr Assay and Application in Assessment of Primary CNS Lymphoproliferative Disorders
Miguel D. Cantu, MD, New York Presbyterian-Weill Cornell, New York, NY, USA 

H28 - Chromosome Arm Gain or Loss by Next Generation Sequencing
Mia Donna Dabrowski, MT(ASCP), AdventHealth Orlando, Orlando, FL, USA 

H44- Comparison of Whole Genome Sequencing (WGS) with Conventional Cytogenetics in Profiling Genome-Wide Large-Scale Copy Number and Structural Variations in Pediatric and Adolescent AML
Lu Wang, MD, PhD, St. Jude Children's Research Hospital, Memphis, TN, USA

Objectives:

  • Analyze platform presentations of abstracts highlighted by the Hematopathology Subdivision leadership as particularly significant.
  • Evaluate the scientific merit and significance of these selected studies through further discussion with the authors.

Recording Date: November 17, 2020


Continuing Education Credit Information

CME/CMLE credit: 1.00 hr
Last day to purchase course and CE claim credit: February 16, 2024

Download the learner notification here
Note: Members of AMP can access this at a discount. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.